LIBERTY 1: A Phase 3 randomized, double-blind, placebo-controlled efficacy & safety study of relugolix co-administered with/without estradiol and norethindrone acetate in women with heavy menstrual bleeding associated with uterine fibroids
. Accessed June 13, 2017